<DOC>
	<DOC>NCT00287066</DOC>
	<brief_summary>To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes</brief_summary>
	<brief_title>A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition</brief_title>
	<detailed_description>The study was terminated on Oct. 28, 2007. The protocol was undergoing implementation and methodological issues with major revisions that qualified this trial as a new trial. Pfizer decided to cancel new trials because of the decision to withdraw Exubera due to lack of market performance and not for safety reasons.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetes mellitus Type 1 Asthma, COPD Smoking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>